Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk

NCT ID: NCT06670677

Last Updated: 2025-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

15000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-05-12

Study Completion Date

2035-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ARM 1:

N1\~ 3'300 subjects.

Research participants are Aktiia G1 users with Android operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with Android operating system. ARM 1 research participants are asked to:

* For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project,
* For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment.
* Additionally, once the Aktiia One App is released and for the next 10 years:
* Take an on-demand measurement with the Aktiia G2C feature (finger measurement) while seated.

ARM 2:

N2\~ 6'600 subjects.

Research participants are Aktiia G1 users with iOS operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with iOS operating system. ARM 2 research participants are asked to:

* For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project,
* For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.
* Additionally, once the Aktiia One App is released and for the next 10 years:
* Take an on-demand measurement with the Aktiia G2C feature (finger measurement) while seated.

ARM 3:

N3\~ 5'000 subjects.

Research participants are non-Aktiia-G1 users (they do not own an Aktiia G1 device at their inclusion in the study), located in Switzerland, Germany or UK, and owning a smartphone with either iOS or Android operating system. ARM 3 research participants are asked to:

* For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.
* At their inclusion in the study: download the Aktiia One App to access G2C functionality with on-demand measurements at fingertip using the smartphone's camera.
* For the next 10 years, starting at their inclusion in the research project and thereafter:

* Take unlimited on-demand measurements with the Aktiia G2C feature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Cardiovascular Risk Blood Pressure Check (Hypertension Screening)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ARM 1 G1 Aktiia users Android

Research participants are Aktiia G1 users with Android operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with Android operating system.

Lifestyle survey completion

Intervention Type OTHER

For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.

Unlimited on-demand blood pressure measurements with G2C

Intervention Type OTHER

For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated

Continual blood pressure measurements with G1

Intervention Type OTHER

For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project.

ARM 2 G1 AKTIIA users iOS

Research participants are Aktiia G1 users with iOS operating system, i.e. individuals who already purchased the Aktiia G1 device out of the context of the study, located in Switzerland, Germany or UK, and owning a smartphone with iOS operating system.

Lifestyle survey completion

Intervention Type OTHER

For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.

Unlimited on-demand blood pressure measurements with G2C

Intervention Type OTHER

For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated

Continual blood pressure measurements with G1

Intervention Type OTHER

For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project.

ARM 3 non-Aktiia-G1-users Android & iOS

Research participants are non-Aktiia-G1 users (they do not own an Aktiia G1 device at their inclusion in the study), located in Switzerland, Germany or UK, and owning a smartphone with either iOS or Android operating system.

Lifestyle survey completion

Intervention Type OTHER

For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.

Unlimited on-demand blood pressure measurements with G2C

Intervention Type OTHER

For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle survey completion

For the next 10 years, starting at their inclusion in the research project and every 6 months thereafter: fill in an online survey on their lifestyle- health- socioeconomic environment. The completion of a survey lasts 5min maximum.

Intervention Type OTHER

Unlimited on-demand blood pressure measurements with G2C

For the next 10 years: take unlimited on-demand measurements with the Aktiia G2C feature (finger measurement) while seated

Intervention Type OTHER

Continual blood pressure measurements with G1

For the next 10 years: wear their 24/7 Aktiia G1 device continuously as they would outside the context of the research project.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Adult subjects aged 21 to 85 years old
2. Subjects living in Switzerland, Germany or in the UK
3. Subjects that are:

Aktiia users owning a smartphone with either iOS or Android operating system (ARMs 1 and 2); or Aktiia non-users owning a smartphone with iOS or Android operating system (ARM 3)
4. Subjects agreeing to follow the study procedures.

Exclusion Criteria

1. Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including resting tachycardia (heart rate at rest \> 120bpm) and atrial fibrillation;
2. Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula;
3. Subjects suffering from polyneuropathy;
4. on pregnant women;
5. Subjects with damaged / injured skin at the wrists (for bracelet measurements) or at index fingers (for camera measurements)
6. Subjects with amputated index fingers (for camera measurements) or amputated upper limb;
7. Subjects below 21 years old and above 85 years old.
Minimum Eligible Age

21 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aktiia SA

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fully remote study- no physical investigational site

Lausanne, , Switzerland

Site Status RECRUITING

Fully remote study- no physical investigational site

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pascale Vermare

Role: CONTACT

+41 32 552 20 52

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pr Wuerzner, MD

Role: primary

+41 21 314 02 23

Dr. Manish SAXENA, MD

Role: primary

0207 882 3856

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNCTP

Identifier Type: OTHER

Identifier Source: secondary_id

OBPM_FORESEE2024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Oura Blood Pressure Profile Study
NCT07267871 NOT_YET_RECRUITING